Home· Settings· Breaking · FrontPage · Extended · Editorial · Activism · News

Prayer  PrayerRequest  SCOTUS  ProLife  BangList  Aliens  HomosexualAgenda  GlobalWarming  Corruption  Taxes  Congress  Fraud  MediaBias  GovtAbuse  Tyranny  Obama  Biden  Elections  POLLS  Debates  TRUMP  TalkRadio  FreeperBookClub  HTMLSandbox  FReeperEd  FReepathon  CopyrightList  Copyright/DMCA Notice 

Monthly Donors · Dollar-a-Day Donors · 300 Club Donors

Click the Donate button to donate by credit card to FR:

or by or by mail to: Free Republic, LLC - PO Box 9771 - Fresno, CA 93794
Free Republic 4th Qtr 2024 Fundraising Target: $81,000 Receipts & Pledges to-date: $20,560
25%  
Woo hoo!! And we're now over 25%!! Thank you all very much!! God bless.

Keyword: pyronaridine

Brevity: Headers | « Text »
  • Scientists suggest that anti-malarial drugs other than Hydroxychloroquine could be repurposed to treat COVID-19

    10/20/2020 8:31:51 AM PDT · by SeekAndFind · 8 replies
    News Medical Life Sciences ^ | 10/20/2020 | Reviewed by Emily Henderson, B.Sc
    An international group of researchers believe there is enough evidence that anti-malarial drugs could be repurposed to treat COVID-19 and that they should be assessed for efficacy in clinical trials. The review article, published online in Trends in Parasitology, outlines the evidence for the antiviral and anti-inflammatory properties of certain anti-malarial drugs that could play a role in tackling COVID-19. The research group, from institutions across Europe, Asia and Africa, point to a combination of the drugs artesunate and pyronaridine as the most promising. Both drugs have demonstrated antiviral effects on the SARS-CoV-2 virus in human lung cells in laboratory...